NALOXONE HCL INJ 0.4 mg/ml OTC (ethical)
NALOXONE HCL INJ 1mg/ml

Trade Agreement: Canadian Free Trade Agreement (CFTA)
Tendering Procedures: All interested suppliers may submit a bid
Competitive Procurement Strategy: Lowest/Lower Bid
Comprehensive Land Claim Agreement: No
Nature of Requirements: 

To supply Naloxone vials on an as-and-when requested basis to the federal/provincial/territorial jurisdictions.

Quantity:

5,000 vials of Naloxone HCL INJ 1mg/ml (2ML)
367,310 vials of Naloxone HCL INJ 0.4 mg/ml OTC (1ML)

Contract period:
From Contract award to June 30, 2020, with an option to extend the contract period for two additional one-year periods from July 1,
2020 to June 30, 2021 and July 1, 2021 to June 30, 2022.

Delivery:
Will be on an as-and-when requested basis.

Trade Agreements:
The provisions of the WTO-AGP, NAFTA, Canada-Chile Free Trade Agreement (CCFTA) and Canada-Columbia Free Trade Agreement (CCOFTA), Canada- Peru Free Trade Agreement (CPFTA) and Canada-European Union Comprehensive
Economic and Trade Agreement (CETA) are not applicable for reasons connected with the protection of human life and health see NAFTA article 1018 para. 2 (a) and (b); WTO-AGP article XXIII (2); CCFTA article Kbis-16 para. 2 (b); CCOFTA article 2201 para 3 (a); CPFTA article 1402 para. 2 (b) and CETA Annex 19-3 para. 2 (b), and because of the absence of regulatory harmonization between Canada and the other signatory countries to the WTO, NAFTA, CCFTA, CCOFTA, CCOPTA, CPFTA
and CETA.

This requirement is subject to the Canadian Free Tree Agreement (CFTA).

This requirement is for the Federal/Provincial/Territorial (F/P/T) Group Purchasing Program for Drugs and Vaccines. Canada is
acting as a purchasing agent for the Federal/Provincial and/or Territorial Governments.
Delivery Date: Above-mentioned

The Crown retains the right to negotiate with suppliers on any procurement.

Documents may be submitted in either official language of Canada.